(SSSS) SuRo Capital - Overview
Sector: Financial Services | Industry: Asset Management | Exchange: NASDAQ (USA) | Market Cap: 352m USD | Total Return: 131.7% in 12m
Avg Turnover: 3.47M
Qual. Beats: 0
Rev. Trend: 82.0%
Qual. Beats: 0
Warnings
Share dilution 27.9% YoY
Tailwinds
Supp Ema20, Leader, Tailwind, Confidence
SuRo Capital Corp. (NASDAQ: SSSS) is a San Francisco-based business development company (BDC) that provides liquidity to late-stage, venture-backed private companies. The firm focuses on growth capital and secondary direct investments within the technology, media, and energy sectors across the United States and Canada.
As a BDC, SuRo Capital allows public shareholders to gain exposure to private equity markets that are typically restricted to institutional investors. The firm maintains a disciplined strategy of seeking minority stakes in companies that have already achieved significant scale or are nearing potential exit events such as an IPO or acquisition.
For a deeper dive into these financial metrics and valuation trends, consider reviewing the detailed reports available on ValueRay. This investment model provides individual investors with a regulated vehicle to participate in the growth of high-profile private enterprises before they transition to public exchanges.
- Late-stage private equity valuations drive net asset value fluctuations
- Portfolio company exit activity through IPOs or acquisitions dictates liquidity
- Rising interest rates impact discount rates for venture-backed startup valuations
- Concentration in technology and media sectors increases sensitivity to growth volatility
- Share repurchases and dividend distributions influence shareholder total return performance
| Net Income: 205.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 10.40 > 1.0 |
| NWC/Revenue: 14.2m% < 20% (prev 231.5%; Δ 14.2m% < -1%) |
| CFO/TA -0.00 > 3% & CFO -2.64m > Net Income 205.3m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (30.2m) vs 12m ago 27.95% < -2% |
| Gross Margin: 94.13% > 18% (prev 0.25%; Δ 9.39k% > 0.5%) |
| Asset Turnover: 0.00% > 50% (prev 2.81%; Δ -2.81% > 0%) |
| Interest Coverage Ratio: 40.93 > 6 (EBITDA TTM -187950b / Interest Expense TTM 5.05m) |
| A: 0.02 (Total Current Assets 43442b - Total Current Liabilities 34191b) / Total Assets 433266b |
| B: -0.00 (Retained Earnings -7.95m / Total Assets 433266b) |
| C: 0.00 (EBIT TTM 206.5m / Avg Total Assets 216633b) |
| D: 0.00 (Book Value of Equity 254b / Total Liabilities 71715b) |
| Altman-Z'' = 0.14 = B |
As of May 24, 2026, the stock is trading at USD 14.00 with a total of 454,801 shares traded.
Over the past week, the price has changed by +5.75%,
over one month by +6.40%,
over three months by +54.88% and
over the past year by +131.74%.
SuRo Capital has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy SSSS.
- StrongBuy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 16.4 | 16.8% |
P/E Forward = 0.7875
P/S = 183.5216
P/B = 0.9085
Revenue TTM = 65.3m USD
EBIT TTM = 206.5m USD
EBITDA TTM = -187950b USD
Long Term Debt = unknown (0.0)
Short Term Debt = 34191b USD (from shortTermDebt, last quarter)
Debt = 34191b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -9125b USD (calculated: Debt 34191b - CCE 43316b)
Enterprise Value = 352.2m USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 40.93 (Ebit TTM 206.5m / Interest Expense TTM 5.05m)
EV/FCF = -133.4x (Enterprise Value 352.2m / FCF TTM -2.64m)
FCF Yield = -0.75% (FCF TTM -2.64m / Enterprise Value 352.2m)
FCF Margin = -4.05% (FCF TTM -2.64m / Revenue TTM 65.3m)
Net Margin = 314.5% (Net Income TTM 205.3m / Revenue TTM 65.3m)
Gross Margin = 94.13% ((Revenue TTM 65.3m - Cost of Revenue TTM 3.83m) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.00 (Enterprise Value 352.2m / Total Assets 433266b)
Interest Expense / Debt = 0.00% (Interest Expense 5.05m / Debt 34191b)
Taxrate = 0.04% (57.6k / 155.7m)
NOPAT = 206.4m (EBIT 206.5m * (1 - 0.04%))
Current Ratio = 1.27 (Total Current Assets 43442b / Total Current Liabilities 34191b)
Debt / Equity = 0.09 (Debt 34191b / totalStockholderEquity, last quarter 361552b)
Debt / EBITDA = 0.05 (negative EBITDA) (Net Debt -9125b / EBITDA -187950b)
Debt / FCF = 3.46m (out of range, set to none) (Net Debt -9125b / FCF TTM -2.64m)
Total Stockholder Equity = 141717b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.00% (Net Income 205.3m / Total Assets 433266b)
RoE = 0.00% (Net Income TTM 205.3m / Total Stockholder Equity 141717b)
RoCE = 0.00% (EBIT 206.5m / Capital Employed (Equity 141717b + L.T.Debt 0.0))
RoIC = 0.00% (NOPAT 206.4m / Invested Capital 433266b)
WACC = 0.00% (E(352.2m)/V(34191b) * Re(10.40%) + D(34191b)/V(34191b) * Rd(0.00%) * (1-Tc(0.00)))
Discount Rate = 10.40% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 51.11 | Cagr: 8.23%
[DCF] Fair Price = unknown (Cash Flow -2.64m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.01 | # QB: 0
Revenue Correlation: 82.03 | Revenue CAGR: 208.6% | SUE: 0.05 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.13 | Chg30d=+16.13% | Revisions=-20% | Analysts=2
EPS next Quarter (2026-09-30): EPS=-0.13 | Chg30d=+18.75% | Revisions=-20% | Analysts=2
EPS current Year (2026-12-31): EPS=4.76 | Chg30d=+816.54% | Revisions=+0% | GrowthEPS=+167.7% | GrowthRev=+30.8%
EPS next Year (2027-12-31): EPS=-0.56 | Chg30d=+22.92% | Revisions=-20% | GrowthEPS=-8.3% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: -20%